Literature DB >> 35099915

Predictors of postoperative seizure outcome in supratentorial meningioma.

Ron Gadot1, A Basit Khan1, Rajan Patel1, Eric Goethe1, Arya Shetty1, Caroline C Hadley1, James C Bayley V1, Akdes S Harmanci1, Tiemo J Klisch2, Daniel Yoshor3, Sameer A Sheth1, Akash J Patel1,2,4.   

Abstract

OBJECTIVE: Meningiomas are the most common primary intracranial tumor. Seizures are common sequelae of meningioma development. Meningioma patients with seizures can be effectively treated with resection, with reports of seizure freedom of 60%-90%. Still, many patients manifest persistent epilepsy. Determining factors associated with worsened seizure outcomes remains critical in improving the quality of life for these patients. The authors sought to identify clinical, radiological, and histological factors associated with worse seizure outcomes in patients with supratentorial meningioma and preoperative seizures.
METHODS: The authors retrospectively reviewed the charts of 384 patients who underwent meningioma resection from 2008 to 2020. The charts of patients with a documented history of preoperative seizures were further reviewed for clinical, radiological, operative, perioperative, histological, and postoperative factors associated with seizures. Engel class at last follow-up was retrospectively assigned by the authors and further grouped into favorable (class I) and worse (class II-IV) outcomes. Factors were subsequently compared by group using comparative statistics. Univariable and multivariable regression models were utilized to identify independent predictors of worse seizure outcome.
RESULTS: Fifty-nine patients (15.4%) were found to have preoperative seizures, of whom 57 had sufficient postoperative data to determine Engel class outcome. Forty-two patients (74%) had Engel class I outcomes. The median follow-up was 17 months. Distinct margins on preoperative imaging (p = 0.012), Simpson grade I resection (p = 0.004), postresection ischemia (p = 0.019), WHO grade (p = 0.019), and recurrent disease (p = 0.015) were found to be the strongest predictors of Engel class outcome in univariable logistic regression. MIB-1 index (p = 0.001) and residual volume (p = 0.014) at last follow-up were found to be the strongest predictors of Engel class outcome in univariable generalized linear regression. Postresection ischemia (p = 0.012), WHO grade (p = 0.022), recurrent disease (p = 0.038), and MIB-1 index (p = 0.002) were found to be the strongest independent predictors of Engel class outcomes in multivariable analysis.
CONCLUSIONS: Postresection ischemia, higher WHO grade, elevated MIB-1 index, and disease recurrence independently predict postresection seizure persistence in patients with supratentorial meningioma. Further understanding of the etiology of these markers may aid in elucidation of this complex disease process and guide management to prevent worse outcomes.

Entities:  

Keywords:  Engel class; meningioma; oncology; outcomes; seizures

Year:  2021        PMID: 35099915     DOI: 10.3171/2021.9.JNS211738

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

Review 1.  Meningioma Related Epilepsy- Pathophysiology, Pre/postoperative Seizures Predicators and Treatment.

Authors:  Rasha Elbadry Ahmed; Hailiang Tang; Anthony Asemota; Lei Huang; Warren Boling; Firas Bannout
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

2.  Proliferative Potential, and Inflammatory Tumor Microenvironment in Meningioma Correlate with Neurological Function at Presentation and Anatomical Location-From Convexity to Skull Base and Spine.

Authors:  Johannes Wach; Tim Lampmann; Ági Güresir; Hartmut Vatter; Ulrich Herrlinger; Albert Becker; Silvia Cases-Cunillera; Michael Hölzel; Marieta Toma; Erdem Güresir
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

3.  Low-Dose Acetylsalicylic Acid Treatment in Non-Skull-Base Meningiomas: Impact on Tumor Proliferation and Seizure Burden.

Authors:  Johannes Wach; Ági Güresir; Hartmut Vatter; Ulrich Herrlinger; Albert Becker; Marieta Toma; Michael Hölzel; Erdem Güresir
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

4.  MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas.

Authors:  Johannes Wach; Motaz Hamed; Tim Lampmann; Ági Güresir; Frederic Carsten Schmeel; Albert J Becker; Ulrich Herrlinger; Hartmut Vatter; Erdem Güresir
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

5.  Brain infarction following meningioma surgery-incidence, risk factors, and impact on function, seizure risk, and patient-reported quality of life.

Authors:  Per S Strand; Lisa M Sagberg; Sasha Gulati; Ole Solheim
Journal:  Neurosurg Rev       Date:  2022-07-28       Impact factor: 2.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.